3 Things Investors Need to Know About Recursion Pharmaceuticals

Recursion Pharmaceuticals (NASDAQ: RXRX) is a relatively small player in the biotech industry. The same is true in artificial intelligence (AI), a market where it is barely on the map, given the giant trillion-dollar companies that dominate it. However, its smaller size may offer Recursion Pharmaceuticals significant upside potential, provided it can establish a foothold in the AI drug discovery niche.Before pulling the trigger, though, there are several things investors should know about Recursion Pharmaceuticals. Here are three them.Recursion Pharmaceuticals uses AI to develop drugs. The company's goal is to improve and speed up a process that is slow, expensive, and risky. Most medicines that enter the clinic never make it to the market as they fail to prove safe or effective (or both) in clinical trials.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool